Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3913475 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kir1.1/ATP-sensitive inward rectifier potassium channel 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293292] [GtoPdb: 429] [UniProtKB: P48048] | ||||||||
ChEMBL | Thallium Flux Assay: The ROMK channel functional thallium flux assay is performed in 384 wells, using the FLIPR-Tetra instrument. HEK-hKir1.1 cells are seeded in Poly-D-Lysine microplates and kept in a 37° C.-10% CO2 incubator overnight. On the day of the experiment, the growth media is replaced with the FluxOR reagent loading buffer and incubated, protected from light, at ambient temperature (23-25° C.) for 90 min. The loading buffer is replaced with assay buffer+/-test compound followed by 30 min incubation at ambient temperature, where the Thallium/Potassium stimulant is added to the microplate.Step Protocol 1. Seed HEK-hKir1.1 cells (50 uA at 20,000 cells/well) in 384-well PDL coated Microplates 2. Allow cells to adhere overnight in humidified 37° C./10% CO2 incubator 3. Completely remove cell growth media from microplate and replace with 25 ul loading buffer 4. Incubate Microplate at room temperature, protected form light, for 90 min. | B | 7.7 | pIC50 | 20 | nM | IC50 | US-9206198-B2. Inhibitors of the renal outer medullary potassium channel (2015) |
ChEMBL | Electrophysiology Assay: Block of Kir1.1 (ROMK1) currents was examined by whole cell voltage clamp (Hamill et. al. Pfluegers Archives 391:85-100 (1981)) using the IonWorks Quattro automated electrophysiology platform (Molecular Devices, Sunnyvale, Calif.). Chinese hamster ovary cells stably expressing Kir1.1 channels were maintained in T-75 flasks in cell culture media in a humidified 10% CO2 incubator at 37° C. Prior to an experiment, Kir1.1 expression was induced by overnight incubation with 1 mM sodium butyrate. On the day of the experiment, cells were dissociated with 2.5 mL of Versene (Invitrogen 15040-066) for approximately 6 min at 37° C. and suspended in 10 mL of bath solution containing (in mM): 150 NaCl, 10 KCl, 2.7 CaCl2, 0.5 MgCl2, 5 HEPES, pH 7.4. After centrifugation, the cell pellet was resuspended in approximately 4.0 mL of bath solution and placed in the IonWorks instrument. The intracellular solution consisted of (in mM): 80 K gluconate, 40 KCl, 20 KF, 3.2 MgCl2, 3 EGTA, 5 Hepes, pH 7.4. | B | 8 | pIC50 | 10 | nM | IC50 | US-9206198-B2. Inhibitors of the renal outer medullary potassium channel (2015) |
GtoPdb | hKir1.1 electrophysiology | - | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
ChEMBL | Inhibition of human ROMK expressed in CHO cells by whole cell voltage clamp electrophysiology assay | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
Kir1.1/ATP-sensitive inward rectifier potassium channel 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2146350] [GtoPdb: 429] [UniProtKB: P35560] | ||||||||
ChEMBL | Inhibition of rat Kir1.1 expressed in HEK293 cells by electrophysiology assay | B | 8.55 | pIC50 | 2.8 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
Kir4.1/ATP-sensitive inward rectifier potassium channel 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2146348] [GtoPdb: 438] [UniProtKB: P78508] | ||||||||
ChEMBL | Inhibition of Kir4.1 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
CYP2C8/Cytochrome P450 2C8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3721] [GtoPdb: 1325] [UniProtKB: P10632] | ||||||||
ChEMBL | Inhibition of CYP2C8 (unknown origin) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
CYP2C9/Cytochrome P450 2C9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3397] [GtoPdb: 1326] [UniProtKB: P11712] | ||||||||
ChEMBL | Inhibition of CYP2C9 (unknown origin) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
CYP2D6/Cytochrome P450 2D6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL289] [GtoPdb: 1329] [UniProtKB: P10635] | ||||||||
ChEMBL | Inhibition of CYP2D6 (unknown origin) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
ChEMBL | Inhibition of CYP3A4 (unknown origin) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
Kir7.1/Inward rectifier potassium channel 13 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2146349] [GtoPdb: 443] [UniProtKB: O60928] | ||||||||
ChEMBL | Inhibition of Kir7.1 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] | ||||||||
ChEMBL | Inhibition of Nav1.5 (unknown origin) | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936] | ||||||||
ChEMBL | Inhibition of Cav1.2 (unknown origin) | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2021) 64: 7691-7701 [PMID:34038119] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]